Page 1

Clinically or
experimentally, it is often useful to calculate the pulmonary
shunt fraction (QS/QT). The pulmonary shunt calculation
estimates the magnitude of the anatomic and physiologic shunts
or the fraction (percentage) of pulmonary blood flow that passes
from the right to left heart without undergoing complete
oxygenation by the lung. The relationships and assumptions
important in the calculation of the shunt fraction are depicted
schematically in the figure. The total O2 in
blood presented for oxygenation by the pulmonary artery is the
mixed venous O2 content (CvO2) multiplied
by total cardiac output (QT), or CvO2 x QT. However,
a portion of this blood flow may be shunted from the left to
right heart without undergoing gas exchange. This flow is
designated as shunt flow (QS). Thereby, the total O2
passing through the shunt is the venous O2 content
multiplied by shunt flow, or QS x CvO2. The remaining
portion of the blood flow is delivered to the alveoli for gas
exchange and equals total flow minus shunt flow, or QT - QS. If
this blood completely equilibrates with the alveolar O2,
then the total amount of O2 leaving the lung
capillaries to enter the pulmonary vein is total flow minus
shunt flow (QT - QS) multiplied by capillary O2
content (CcO2), or (QT - QS) x CcO2. In
the systemic circulation, the total O2 delivered to
the tissues is the systemic arterial O2 content (CaO2)
multiplied by cardiac output (QT), or CaO2 x QT. If
it is assumed that total right heart cardiac input or venous
return (QTinflow) is equal to left heart cardiac
output (QToutflow), then O2 delivered to
the tissues from the left heart (QT x CaO2 ) is the
sum of O2 content in shunt flow (QS x CvO2)
and O2 content in alveolar blood flow, or (QT - QS) x
CcO2 as expressed in the equation:

If it is assumed no diffusion limitation
is present and complete O2
equilibration occurs between the alveoli and capillary blood, then the
capillary PO2 is
equal to alveolar PO2.
Since it is difficult to sample capillary blood to measure the PO2
or CcO2, the CcO2
is usually derived from a measurement of the alveolar PO2
and expressed as CAO2.
By substituting CAO2
for CcO2, and
rearranging the equation, the shunt fraction (QS/QT) is calculated as:

Page 2
Intrapulmonary shunting is defined as the
portion of the cardiac output that perfuses through the lung
without coming in contact with ventilated alveoli. This portion
of the cardiac output, therefore, passes through the lungs and
into the left side of the heart without being oxygenated.
In the normal, healthy person,
intrapulmonary shunting occurs. This results from blood flow
through the bronchial, pleural, and thebesian veins. These veins
return blood to the left atrium, therefore bypassing the
oxygenation process in the lungs (called an anatomic shunt).
Normally, intrapulmonary shunting is about 2% to 5% of the
cardiac output and is primarily caused by anatomic shunting.
Physiologic shunting represents only a
small portion of the normal anatomic shunt. Increased
physiologic shunting results in a worsening cardiopulmonary
status.
Conditions that increase physiologic
shunting:
-
Pneumonia
-
Pneumothorax
-
Pulmonary edema
-
Atelectasis
The amount of shunt may be determined using
the clinical shunt formula:

This formula requires a 100% Hb saturation
of O2 in arterial blood.
If measurement of PVO2 is not
available, (via pulmonary artery catheter), the modified shunt
equation may be used:

Calculate a patients percentage of shunt
given the following data:
|
pH |
7.37 |
|
PaCO2 |
45 mm Hg |
|
PaO2 |
60 mm Hg |
|
FiO2 |
0.40 |
|
PB |
747 torr |
PaO2 = (PB – 47)(FiO2) – (PaCO2 x 1.25)
(747 – 47)(.4) – (45 x 1.25)
280 - 56 =
224 torr



= .098
QS/QT = .098 x 100 = 9.8%
This means that almost 10% of the patients
cardiac output is not being oxygenated in the lungs.
A simplified method of calculating shunt
is:
A-a gradient / 20 + 4%
Interpreting calculated shunt values:
-
Less
than 10% is normal
-
10% to
20% is abnormal intrapulmonary status that is usually of no
significance clinically.
-
20% to
30% is significant intrapulmonary disease, which may be life
threatening and require cardiopulmonary support.
-
More
than 30% is a serious, life threatening condition, which
requires aggressive cardiopulmonary support.